Hypomania News and Research

RSS

Forest Laboratories, Pierre Fabre Laboratories announce that FETZIMA gets FDA approval for MDD

Forest Laboratories, Inc. and Pierre Fabre Laboratories announced today that FETZIMA (levomilnacipran extended-release capsules), a once-daily serotonin and norepinephrine reuptake inhibitor, discovered by Pierre Fabre Laboratories and co-developed by Forest Laboratories, Inc. was approved by the U.S. Food and Drug Administration for the treatment of Major Depressive Disorder in adults.

26 Jul 2013

Antidepressants cause mood elevation and behavioral activation in children and adolescents

A paper published in the current issue of P&P by a group of researchers of the University of Bologna (headed by Professor Giovanni Fava) and a Harvard psychopharmacologist (professor Ross Baldessarini) has analyzed data that derive from randomized controlled trials concerned with the use of antidepressant drugs in children and adolescents.

27 May 2013

Continuous circular cycling ‘a distinct bipolar disorder subtype’

Results from an Italian study suggest that there are distinct differences in clinical presentation, outcome, and treatment response between bipolar disorder patients with and without intervals between mood episodes.

30 Apr 2013

Bipolar disorder questionnaires limited for patients with SUD

Researchers advise caution when using the Mood Disorder Questionnaire and the Hypomania Checklist-32 to diagnose bipolar disorder in patients treated for substance use disorders.

25 Apr 2013

Family-focused therapy improves mood symptoms in youth at risk of bipolar disorder

A study published in the February 2013 issue of the Journal of the American Academy of Child and Adolescent Psychiatry found that children and adolescents with major depression or subthreshold forms of bipolar disorder - and who had at least one first-degree relative with bipolar disorder - responded better to a 12-session family-focused treatment than to a briefer educational treatment.

8 Mar 2013

Misdiagnosed bipolar depression has subtle clinical features

Increased appetite, sleep, and weight gain, among other clinical features, can be used to help identify patients with bipolar disorder who have been misdiagnosed with major depressive disorder.

5 Mar 2013

Bipolar disorder ‘frequent’ in depressive borderline personality disorder

Study results indicate that bipolar disorder may occur in up to half of individuals with co-existing borderline personality disorder and depression.

14 Feb 2013

Bipolar disorder ‘frequent’ in depressive borderline personality disorder

Study results indicate that bipolar disorder may occur in up to half of individuals with co-existing borderline personality disorder and depression.

12 Feb 2013

Mental health risk increased in problem gamblers

Individuals with a gambling problem are at increased risk for developing Axis I psychiatric disorders, results from a US study show.

5 Feb 2013

Family history best discriminator of bipolar disorder from depression in young people

A family history of bipolar, psychotic, or substance use disorders best differentiates adolescents and young adults with emerging bipolar disorder from those with unipolar depression, say Australian researchers.

4 Dec 2012

Bipolarity common in major depressive episode patients

Results from an Egyptian study show that a substantial proportion of patients being treated for a major depressive episode may have underlying bipolarity.

29 Nov 2012

Subthreshold bipolarity common in major depressive disorder

Results from a Polish study show that a substantial proportion of patients with major depressive disorder meet criteria for subthreshold bipolarity.

27 Nov 2012

BD prevalence in depression varies according to diagnostic method

The prevalence of bipolar disorder in patients with a major depressive episode varies widely depending on the diagnostic method used, researchers report.

31 Oct 2012

AACAP honors Pittsburgh psychiatric professor with Klingenstein Third Generation Foundation award

The American Academy of Child and Adolescent Psychiatry (AACAP) is pleased to announce David A. Axelson, M.D, Assistant Professor of Psychiatry, University of Pittsburgh School of Medicine, and Western Psychiatric Institute and Clinic, and Director, Child and Adolescent Bipolar Services, Western Psychiatric Institute and Clinic, as the recipient of the Klingenstein Third Generation Foundation Award for Research in Depression or Suicide for his paper, "Course of Subthreshold Bipolar Disorder in Youth: Diagnostic Progression From Bipolar Disorder Not Otherwise Specified," published in the October 2011 issue of the Journal of the American Academy of Child and Adolescent Psychiatry.

29 Oct 2012